Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready
BAO FENG BIOTECH (BEIJING) CO., LTD has 2 pending office actions in Chemistry & Materials. The record identifies 2 distinct examiners and 2 distinct art units, requiring attention across separate examination channels.
FRITCHMAN, REBECCA M is the busiest examiner, with 1 pending matter. Counsel can maintain a consistent materials strategy while tailoring claim arguments and amendments to each prosecution record.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Double-patenting + other | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| FRITCHMAN, REBECCA M | 1 | 45.6% | +35.4% |
| MACFARLANE, STACEY NEE | 1 | 53.7% | +39.5% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18021229 | METHOD FOR DIAGNOSING ACTING OF NERVONIC ACID AND USE THEREOF | FRITCHMAN, REBECCA M | 6d |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18021229 | METHOD FOR DIAGNOSING ACTING OF NERVONIC ACID AND USE THEREOF | FRITCHMAN, REBECCA M | 6d |
| 18021211 | METHOD FOR DIAGNOSING AND TREATING COGNITIVE IMPAIRMENT AND USE THEREOF | MACFARLANE, STACEY NEE | — |
| Art Unit | Apps |
|---|---|
| 1758 | 1 |
| 1675 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18021229 | METHOD FOR DIAGNOSING ACTING OF NERVONIC ACID AND USE THEREOF | FRITCHMAN, REBECCA M | 1758 | §103§112 | Non-Final OA | 6d | Pending | Feb 14, 2023 |
| 18021211 | METHOD FOR DIAGNOSING AND TREATING COGNITIVE IMPAIRMENT AND USE THEREOF | MACFARLANE, STACEY NEE | 1675 | §103DP | Non-Final OA | — | Pending | Feb 14, 2023 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialBAO FENG BIOTECH (BEIJING) CO., LTD has 2 pending office actions as of October 2026, spread across 2 art units and 2 examiners.
Rebecca M Fritchman has the most, with 1 of BAO FENG BIOTECH (BEIJING) CO., LTD's pending office actions.
Mostly Chemistry & Materials (USPTO Tech Center 1700), based on where its pending office actions are examined.
